尾島 英知

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Cholangiocarcinoma 76%
3. Neoplasms 49%
4. Liver 36%
5. Biliary Tract 31%
6. Genome 25%
7. Biliary Tract Neoplasms 25%
8. Carcinoma 23%
9. Bile Duct Neoplasms 20%
10. Hepatectomy 19%
11. Bile Ducts 18%
12. Margins of Excision 18%
13. Mutation 16%
14. Liver Neoplasms 16%
15. gemcitabine 15%
16. DNA Methylation 14%
17. Survival 13%
18. Recurrence 12%
19. Neoplasm Metastasis 11%
20. Whole Genome Sequencing 11%
21. Cell Line 10%
22. Proteomics 10%
23. Adenocarcinoma 10%
24. Carcinoma, Intraductal, Noninfiltrating 10%
25. Fatty Liver 9%
26. Pancreas 9%
27. Genes 9%
28. Gallbladder Neoplasms 9%
29. Pancreaticoduodenectomy 9%
30. Axitinib 9%
31. Carcinogenesis 8%
32. Therapeutics 8%
33. Pancreatic Ducts 8%
34. Carcinosarcoma 8%
35. Klatskin Tumor 8%
36. Biomarkers 8%
37. Hepatocytes 8%
38. Vascular Endothelial Growth Factor A 7%
39. Proteins 7%
40. ErbB Receptors 7%
41. Intrahepatic Bile Ducts 7%
42. Organoids 7%
43. Japan 7%
44. Exome 7%
45. Growth 7%
46. Epigenome 7%
47. Catenins 7%
48. Right Ventricular Hypertrophy 6%
49. Phenotype 6%
50. Chromatin 6%